NCT01078623 - Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Aclidinium 200 μg / formoterol 12 μg

Aclidinium bromide 200 μg + formoterol fumarate 12 μg fixed dose combination (FDC) twice daily

DRUG

Placebo

Placebo control twice daily

DRUG

Formoterol 12 μg

Formoterol fumarate 12 μg twice daily

DRUG

Aclidinium 200 μg

Aclidinium bromide 200 μg twice daily

DRUG

Aclidinium 200 μg / Formoterol 6 μg

Aclidinium bromide 200 μg + formoterol fumarate 6 μg fixed dose combination (FDC) twice daily

Trial Locations (10)

Research Site, Bucuresti

Research Site, Constanta

Research Site, Iasi

Research Site, Tg Mures

Research Site, Bucharest

Research Site, Cluj-Napoca

Research Site, Deva

Research Site, Iași

Research Site, Oradea

Research Site, Timișoara